DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Brivanib is an investigational drug.
There have been 24 clinical trials for Brivanib. The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2009.
The most common disease conditions in clinical trials are Carcinoma, Carcinoma, Hepatocellular, and Colorectal Neoplasms. The leading clinical trial sponsors are Bristol-Myers Squibb, Zai Lab (Shanghai) Co., Ltd., and Gynecologic Oncology Group.
Recent Clinical Trials for Brivanib
|MGD013 Monotherapy and Combination With Brivanib Dose Escalation and Expansion Study in Advanced Liver Cancer Patients||Zai Lab (Shanghai) Co., Ltd.||Phase 1/Phase 2|
|A Study of Niraparib in Combination With Brivanib in Recurrent Ovarian Cancer||Hunan Cancer Hospital||Phase 1|
|A Phase 2 Study of Brivanib in Chinese Patients With Previously Treated Advanced HCC||Zai Lab (Shanghai) Co., Ltd.||Phase 2|